Deb Lancaster was appointed Novartis Oncology Head of Market Access for the UK in March 2018. Prior to this, Deb worked at Roche UK for 15 years, in a variety of roles including Breast Cancer Marketing Manager, Business Insights and Operations Director and most recently Market Access Director, responsible for the entire Roche portfolio. In the latter role Deb was a media spokesperson, and acted as a witness on the Public Accounts Committee enquiry into the Cancer Drug Fund. Before Roche, Deb held a number of different roles at Schering-Plough and Napp, ranging from OTC to oncology marketing. Deb holds a degree in Genetics and Microbiology from the University of Leeds, and is a Chartered Marketeer.